Emami to Acquire Complete Stake in Axiom Ayurveda, Enters Beverage Sector
Kolkata, April 2, 2026 – Emami Limited has executed a definitive agreement on April 1, 2026, to acquire the remaining stake in Axiom Ayurveda Pvt Ltd ('Axiom'), subject to customary closing conditions.The acquisition will be completed in a phased manner over the next three months. In the initial tranche, Emami acquired an additional ~36.7% stake, building on its existing ~26.5% stake. The total consideration for the acquisition is capped at Rs.200 crores.
Axiom's portfolio includes beverage products under the brand 'AloFrut', health juices under the brand 'Axiom Jeevan Ras', and beauty products under the brand 'Mukti Gold'. AloFrut juices, featuring aloe vera pulp blended with fruit, are marketed as a refreshing and healthy beverage.
Mr. Harsha Vardhan Agarwal, Vice Chairman & MD of Emami Ltd., stated that the acquisition marks Emami’s formal entry into the beverage sector, aligning with the company's strategy to expand into high-opportunity categories and cater to evolving consumer preferences in the health and wellness space. Axiom is expected to achieve a topline of approximately Rs.180 crore in fiscal year 2026.
Rishabh Gupta, Founder of Axiom Ayurveda Pvt Ltd., expressed confidence in Emami's ability to scale the company further and unlock its full potential.
To facilitate the company’s growth, Mr. Harkirat Bedi, formerly Vice President & Business Head at Dabur Nepal, has been appointed as the Chief Executive Officer of Axiom Ayurveda Pvt. Ltd.
About Emami Limited:
Emami Limited (NSE: EMAMILTD, BSE: 531162), founded in 1974, is a leading fast-moving consumer goods (FMCG) company with a diverse portfolio including brands like Navratna, BoroPlus, Fair & Handsome, Zandu Balm, Mentho Plus and Kesh King.
About Axiom Ayurveda Pvt Ltd:
Axiom Ayurveda was incorporated in 1995 and produces fruit juices under the 'AloFrut' brand, herbal juices under the brand 'Jeevan Ras', and beauty products under the brand 'Mukti Gold'.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.